Trump/Kennedy FDA Approves Moderna mRNA-1010 Influenza Shot 'mFLUSIVA' with Less Than 1% Absolute Benefit and 6 Times More Severe Reactions

FDA approved the injection for seniors before any clinical benefit was shown, and before confirming vaccinated can't shed vaccine components onto unvaccinated, raising informed consent concerns.